Program Director [clinicaltrials_resource:3c6022ae5b4a7c80195bd82f2c438f54]
An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A [clinicaltrials:NCT02172950]An Observational Cohort Study of the Safety and Efficacy of Fibrinogen Concentrate, Human (FCH) in Subjects With Congenital Fibrinogen Deficiency [clinicaltrials:NCT02427217]
overall contact [clinicaltrials_vocabulary:overall-contact]
Program Director [clinicaltrials_resource:3c6022ae5b4a7c80195bd82f2c438f54]
Bio2RDF identifier
3c6022ae5b4a7c80195bd82f2c438f54
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:3c6022ae5b4a7c80195bd82f2c438f54
affiliation [clinicaltrials_vocabulary:affiliation]
email [clinicaltrials_vocabulary:email]
clinicaltrials@cslbehring.com
last name [clinicaltrials_vocabulary:last-name]
Program Director
role [clinicaltrials_vocabulary:role]
Study Director
identifier
clinicaltrials_resource:3c6022ae5b4a7c80195bd82f2c438f54
title
Program Director
@en
type
label
Program Director [clinicaltrials_resource:3c6022ae5b4a7c80195bd82f2c438f54]
@en